Carcinogenesis · 2012 · 22 citations · 15 references
Life SciencesCell BiologyOncologyApoptosisCell SignalingSignal TransductionApoptosis In CancerApoptosis RegulationCancer Cell SignalingCaspase ActivationMalignant NeoplasmsTyrosine Kinase InhibitorsApoptosis Regulation By KinasesCancer Signaling PathwaysCaspase-mediated ApoptosisKinase InhibitorsMap KinasesSrc Family ActivationSrc Family Kinase InhibitorsSrc Family Kinases
Malignant mesothelioma is an aggressive tumor arising from mesothelial cells of serous membranes. Src family kinases (SFKs) have a pivotal role in cell adhesion, proliferation, survival and apoptosis. Here, we examined the effect of SFK inhibitors in NCI-H2052, ACC-MESO-4 and NCI-H28 cells, mesothelioma cell lines and Met5A, a human non-malignant mesothelial cell line. We found that PP2, a selective SFK inhibitor, inhibited SFK activity and induced apoptosis mediated by caspase-8 in NCI-H28 but not Met5A, NCI-H2052 and ACC-MESO-4 cells. Src, Yes, Fyn and Lyn protein, which are members of the SFK, were expressed in these cell lines, whereas NCI-H28 cells were deficient in Fyn protein. Small interfering RNA (siRNA) targeting Fyn facilitated PP2-induced apoptosis mediated by caspase-8 in NCI-H2052 and ACC-MESO-4 cells. PP2 reduced Lyn protein levels and suppressed SFK activity in all mesothelioma cell lines. Lyn siRNA induced caspase-8 activation and apoptosis in NCI-H28 cells but not in NCI-H2052 and ACC-MESO-4 cells. However, double RNA interference knockdown of Fyn and Lyn induced apoptosis accompanied by caspase-8 activation in NCI-H2052 and ACC-MESO-4 cells. Dasatinib, an inhibitor of multi-tyrosine kinases including SFK, also inhibited SFK activity and induced reduction of Lyn protein levels, caspase-8 activation and apoptosis in NCI-H28 cells but not in other cell lines. Present study suggests that SFK inhibitors induce caspase-8-dependent apoptosis caused by reduction of Lyn protein in Fyn-deficient mesothelioma cells.
15
A chemical and phosphoproteomic characterization of dasatinib action in lung cancer
Jiannong Li, Uwe Rix, Bin Fang et al. · Nature Chemical Biology · 2010 · 283 citations · Full text
Medicine, Biochemistry, Oncology +13
LYN Is a Mediator of Epithelial-Mesenchymal Transition and a Target of Dasatinib in Breast Cancer
Yoon‐La Choi, Melanie Bocanegra, Mi Kwon et al. · Cancer Research · 2010 · 152 citations · Full text